1808751-57-6
1808751-57-6
Chemical Structure
DDAH1-IN-3
- CAS. Nr.: 1808751-57-6
- Formula:C13H19N3O
- Molecular Weight:233.31
InChIKey: GBOUVNNKIAAHMQ-UHFFFAOYSA-N
SMILES: CC1=CC(C/N=C(N)/NC2CC2)=CC=C1OC
Biological Activity: DDAH1-IN-3 is a DDAH1 inhibitor with a human IC50 of 176 μM. DDAH1-IN-3 binds to the DDAH1 active site, forms binding interactions that remodel the binding pocket, and functionally inhibits the enzyme. DDAH1-IN-3 suppresses vasculogenic mimicry in triple-negative breast cancer cells. DDAH1-IN-3 can be used for the research of triple-negative breast cancer[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DDAH1-IN-3 | DDAH1-IN-3 is a DDAH1 inhibitor with a human IC50 of 176 μM. DDAH1-IN-3 binds to the DDAH1 active site, forms binding interactions that remodel the binding pocket, and functionally inhibits the enzyme. DDAH1-IN-3 suppresses vasculogenic mimicry in triple-negative breast cancer cells. DDAH1-IN-3 can be used for the research of triple-negative breast cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
